- 专利标题： Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
-
申请号： US16238277申请日： 2019-01-02
-
公开(公告)号： US10813930B2公开(公告)日： 2020-10-27
- 发明人: Wenqing Yao , Colin Zhang , Meizhong Xu , Jincong Zhuo , Chunhong He
- 申请人： Incyte Corporation , Incyte Holdings Corporation
- 申请人地址： US DE Wilmington US DE Wilmington
- 专利权人： Incyte Corporation,Incyte Holdings Corporation
- 当前专利权人： Incyte Corporation,Incyte Holdings Corporation
- 当前专利权人地址： US DE Wilmington US DE Wilmington
- 代理机构： Fish & Richardson P.C.
- 主分类号： C07D401/12
- IPC分类号： C07D401/12 ; A61K31/5025 ; C07D401/14 ; C07D403/12 ; C07D405/12 ; C07D405/14 ; C07D407/12 ; C07D487/04 ; C07D235/06 ; C07D403/04 ; A61K31/5377
摘要：
The present invention relates to substituted imidazopyridazines and substituted benzimidazoles, as well as pharmaceutical compositions comprising the same, which are FGFR3 inhibitors useful in the treatment of cancer and other diseases.
公开/授权文献
信息查询
